Vered Caplan

CEO at Orgenesis, Inc.

Speaker

Vered Caplan is CEO of Orgenesis Inc, a global biotech company working to unlock the full potential of cell and gene therapies in an affordable and accessible format at the point of care. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production.Prior to Orgenesis, Vered has been CEO of Kamedis, a company focused on utilizing plant extracts for dermatology purposes. From 2004 to 2007, Ms. Caplan was CEO of GammaCan, a company focused on the use of immunoglobulins for the treatment of cancer. During the previous five years, Ms. Caplan has been a director of numerous companies in the biotech industry, among them: Inmotion Ltd., a company involved with self-propelled disposable colonoscopies; Nehora Photonics Ltd., a company involved with non-invasive blood monitoring and others.

Ms. Caplan has been a regular commentator and key opinion leader, and a multiple entry to The Medicine Maker’s Power List, a group of selected senior leaders in the life science industry that generate most influence in the sector. She has appeared on podcasts and broadcast interviews from The Big Biz Show, Cell & Gene: The Podcast, The Video Journal of Regenerative Medicine and The Science Advisory Board. She is regularly interviewed by top publications in the life science and cell and gene sector, including STAT News, Genetic Engineering News, Scrip, Fierce, FirstWord Pharma and BioWorld.

Ms. Caplan has a M.Sc. in biomedical engineering from Tel Aviv University specializing in signal processing; management for engineers from Tel Aviv University specializing in business development; and a B.Sc. in mechanical engineering from the Technion-Israel Institute of Technology specialized in software and cad systems.